Low back pain? There’s good and bad news

Researchers performed a meta-analysis on the clinical course of acute, subacute, and persistent lower back pain.

Tonix acquires Upsher-Smith’s migraine products

Zembrace SymTouch 3mg and Tosymra 10mg are intended to treat adults with acute migraine. Credit: Towfiqu barbhuiya on Unsplash. Tonix Pharmaceuticals and Tonix Medicines have acquired

July 4, 2023

Triveni scores $115m to expand immunology pipeline – Pharmaceutical Technology

TRIV-573 is a preclinical bispecific antibody designed to target KLK5/7 and interleukin IL-13. Credits: Kmpzzz / Shutterstock. Triveni Bio has secured $115m in a Series

October 2, 2024

In Brief: ICER Issues Final Evidence Report and Recommendations Re: MDMA-Assisted Therapy; Lykos Responds – Psychedelic Alpha

Aside from issuing its final report (which we don’t discuss in detail here owing to its similarity to that discussed in our earlier coverage, above),

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.